Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.
CD155
CD96
ER stress
IL-9
T cell
autoimmune vasculitis
autoimmunity
giant cell arteritis
immune checkpoint receptors
macrophage
Journal
Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894
Informations de publication
Date de publication:
18 04 2023
18 04 2023
Historique:
received:
24
10
2022
revised:
13
02
2023
accepted:
21
03
2023
medline:
21
4
2023
pubmed:
20
4
2023
entrez:
19
04
2023
Statut:
ppublish
Résumé
Loss of function of inhibitory immune checkpoints, unleashing pathogenic immune responses, is a potential risk factor for autoimmune disease. Here, we report that patients with the autoimmune vasculitis giant cell arteritis (GCA) have a defective CD155-CD96 immune checkpoint. Macrophages from patients with GCA retain the checkpoint ligand CD155 in the endoplasmic reticulum (ER) and fail to bring it to the cell surface. CD155
Identifiants
pubmed: 37075705
pii: S2666-3791(23)00122-2
doi: 10.1016/j.xcrm.2023.101012
pmc: PMC10140609
pii:
doi:
Substances chimiques
Cytokines
0
Antigens, CD
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
101012Subventions
Organisme : NIAID NIH HHS
ID : R01 AI108906
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR042527
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL117913
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142068
Pays : United States
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests K.J.W. has received clinical trial support from Eli Lilly, GSK, and Kiniksa; he received consulting fees and honoraria from Chemocentryx.
Références
JCI Insight. 2018 Oct 18;3(20):
pubmed: 30333306
Cell. 2010 Mar 19;140(6):900-17
pubmed: 20303879
J Immunol. 2000 Jun 1;164(11):5556-63
pubmed: 10820229
J Am Coll Cardiol. 2019 Apr 16;73(14):1811-1823
pubmed: 30975299
Eur J Immunol. 2020 Jun;50(6):891-902
pubmed: 32043568
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5783-8
pubmed: 12724521
J Clin Invest. 2017 Jun 30;127(7):2725-2738
pubmed: 28604383
J Immunol. 2011 Feb 1;186(3):1338-42
pubmed: 21199897
Curr Opin Immunol. 2012 Apr;24(2):246-51
pubmed: 22285893
J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):108-15
pubmed: 10629460
Int Immunol. 2007 Jul;19(7):813-24
pubmed: 17606980
Cancer Cell. 2018 Jun 11;33(6):1048-1060.e7
pubmed: 29894691
Gut. 2015 May;64(5):743-55
pubmed: 24957265
Cell Mol Immunol. 2019 Jan;16(1):40-52
pubmed: 30275538
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13175-80
pubmed: 9371819
Mod Pathol. 2017 Jun;30(6):788-796
pubmed: 28256573
Nat Rev Immunol. 2021 Jan;21(1):37-48
pubmed: 32788707
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E970-E979
pubmed: 28115719
J Exp Med. 2004 Jan 19;199(2):173-83
pubmed: 14734523
Nature. 1990 Nov 8;348(6297):125-32
pubmed: 2122258
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 32960812
PLoS One. 2013;8(1):e54406
pubmed: 23349877
Cardiovasc Res. 2015 Jun 1;106(3):453-64
pubmed: 25784693
Sci Rep. 2017 Sep 5;7(1):10445
pubmed: 28874810
J Clin Invest. 2015 May;125(5):2046-58
pubmed: 25866972
Circ Res. 2018 Aug 31;123(6):700-715
pubmed: 29970365
Nature. 2006 Aug 31;442(7106):997-1002
pubmed: 16921386
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12885-90
pubmed: 19433802
Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):E2940-E2949
pubmed: 29531070
Nat Immunol. 2009 Jan;10(1):48-57
pubmed: 19011627
Circ Res. 2023 Jan 20;132(2):238-250
pubmed: 36656970
Nat Rev Dis Primers. 2022 Jan 6;7(1):93
pubmed: 34992251
Rheumatology (Oxford). 2015 Sep;54(9):1596-604
pubmed: 25862016
J Cell Biol. 2004 Oct 11;167(1):35-41
pubmed: 15466483
Oncogene. 2018 Sep;37(39):5269-5280
pubmed: 29855615
J Allergy Clin Immunol. 2000 Sep;106(3):460-6
pubmed: 10984364
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17858-63
pubmed: 19815499
Circulation. 2011 Jan 25;123(3):309-18
pubmed: 21220737
J Exp Med. 2016 Mar 7;213(3):337-54
pubmed: 26926996
Annu Rev Immunol. 2016 May 20;34:539-73
pubmed: 26927206
Front Immunol. 2018 May 17;9:1072
pubmed: 29868026
Semin Immunopathol. 2017 Jan;39(1):11-20
pubmed: 27837254
Immunity. 1999 Oct;11(4):391-8
pubmed: 10549621
Biochem J. 2006 Nov 15;400(1):163-8
pubmed: 16842238
Nat Immunol. 2014 Jul;15(7):676-86
pubmed: 24908389
Arthritis Rheum. 1990 Aug;33(8):1122-8
pubmed: 2202311
Circulation. 2018 May 1;137(18):1934-1948
pubmed: 29254929
Immunity. 1996 Jun;4(6):573-81
pubmed: 8673704
Nat Med. 2012 Aug;18(8):1248-53
pubmed: 22772464
J Hematol Oncol. 2020 Jun 12;13(1):76
pubmed: 32532329
J Biol Chem. 2002 Mar 8;277(10):7897-904
pubmed: 11751937
Nat Cardiovasc Res. 2022 Jul;1(7):634-648
pubmed: 36860353
Arthritis Rheum. 2012 Jun;64(6):2001-11
pubmed: 22147555
J Exp Med. 2019 Jun 3;216(6):1244-1254
pubmed: 31068379
J Clin Invest. 2012 Nov;122(11):4160-71
pubmed: 23064366
Nat Immunol. 2014 May;15(5):431-8
pubmed: 24658051
Nat Rev Rheumatol. 2013 Dec;9(12):731-40
pubmed: 24189842
Immunol Rev. 2017 Mar;276(1):112-120
pubmed: 28258695
Nat Rev Dis Primers. 2020 May 7;6(1):38
pubmed: 32382051
J Exp Med. 2009 Aug 3;206(8):1653-60
pubmed: 19596803
Sci Transl Med. 2017 Jul 19;9(399):
pubmed: 28724574
Autoimmunity. 2009 Nov;42(7):596-604
pubmed: 19657775
J Exp Med. 2013 Dec 16;210(13):2951-65
pubmed: 24249111
J Cell Sci. 2009 May 15;122(Pt 10):1626-36
pubmed: 19420237